Cargando…

Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor

BACKGROUND: Disruption of bile acid (BA) homeostasis plays a key role in intestinal inflammation. The gut-liver axis is the main site for the regulation of BA synthesis and BA pool size via the combined action of the nuclear Farnesoid X Receptor (FXR) and the enterokine Fibroblast Growth Factor 19 (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gadaleta, Raffaella Maria, Garcia-Irigoyen, Oihane, Cariello, Marica, Scialpi, Natasha, Peres, Claudia, Vetrano, Stefania, Fiorino, Gionatha, Danese, Silvio, Ko, Brian, Luo, Jian, Porru, Emanuele, Roda, Aldo, Sabbà, Carlo, Moschetta, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136604/ https://www.ncbi.nlm.nih.gov/pubmed/32259714 http://dx.doi.org/10.1016/j.ebiom.2020.102719

Ejemplares similares

Corrigendum to ‘Fibroblast growth factor 19 modulates intestinal microbiota and inflammation in presence of farnesoid x receptor’: [EBioMedicine 54 (2020) 102719]
por: Gadaleta, Raffaella Maria, et al.
Publicado: (2020)

Suppression of Hepatic Bile Acid Synthesis by a non-tumorigenic FGF19 analogue Protects Mice from Fibrosis and Hepatocarcinogenesis
por: Gadaleta, Raffaella Maria, et al.
Publicado: (2018)

Long-term Administration of Nuclear Bile Acid Receptor FXR Agonist Prevents Spontaneous Hepatocarcinogenesis in Abcb4(−/−) Mice
por: Cariello, Marica, et al.
Publicado: (2017)

Total serum FGF-21 levels positively relate to visceral adiposity differently from its functional intact form
por: Crudele, Lucilla, et al.
Publicado: (2023)

Intestinal FXR Activation via Transgenic Chimera or Chemical Agonism Prevents Colitis-Associated and Genetically-Induced Colon Cancer
por: Cariello, Marica, et al.
Publicado: (2022)

Bile Salt Hydrolase-Competent Probiotics in the Management of IBD: Unlocking the “Bile Acid Code”
por: Gadaleta, Raffaella Maria, et al.
Publicado: (2022)

Gut microbiota in the pathogenesis and therapeutic approaches of diabetes
por: Crudele, Lucilla, et al.
Publicado: (2023)

Reduction in gut‐derived MUFAs via intestinal stearoyl‐CoA desaturase 1 deletion drives susceptibility to NAFLD and hepatocarcinoma
por: Ducheix, Simon, et al.
Publicado: (2022)

Serum Bile Acids Profiling in Inflammatory Bowel Disease Patients Treated with Anti-TNFs
por: Roda, Giulia, et al.
Publicado: (2019)

Extra-Virgin Olive Oil from Apulian Cultivars and Intestinal Inflammation
por: Cariello, Marica, et al.
Publicado: (2020)

Extra Virgin Olive Oil: Lesson from Nutrigenomics
por: De Santis, Stefania, et al.
Publicado: (2019)

Low HDL-cholesterol levels predict hepatocellular carcinoma development in individuals with liver fibrosis
por: Crudele, Lucilla, et al.
Publicado: (2022)

Identification of a Novel Score for Adherence to the Mediterranean Diet That Is Inversely Associated with Visceral Adiposity and Cardiovascular Risk: The Chrono Med Diet Score (CMDS)
por: De Matteis, Carlo, et al.
Publicado: (2023)

Metabolic syndrome and idiopathic sudden sensori-neural hearing loss
por: Rinaldi, Massimo, et al.
Publicado: (2020)

Enterocyte superoxide dismutase 2 deletion drives obesity
por: Garcia-Irigoyen, Oihane, et al.
Publicado: (2021)

Adhesion of Platelets to Colon Cancer Cells Is Necessary to Promote Tumor Development in Xenograft, Genetic and Inflammation Models
por: Cariello, Marica, et al.
Publicado: (2021)

Role of Oleic Acid in the Gut-Liver Axis: From Diet to the Regulation of Its Synthesis via Stearoyl-CoA Desaturase 1 (SCD1)
por: Piccinin, Elena, et al.
Publicado: (2019)

AST/ALT-to-platelet ratio (AARPRI) predicts gynaecological cancers: a 8-years follow-up study in 653 women
por: Crudele, Lucilla, et al.
Publicado: (2023)

AST to Platelet Ratio Index (APRI) is an easy-to-use predictor score for cardiovascular risk in metabolic subjects
por: De Matteis, Carlo, et al.
Publicado: (2021)

Transcriptional Regulation of Metabolic Pathways via Lipid-Sensing Nuclear Receptors PPARs, FXR, and LXR in NASH
por: Cariello, Marica, et al.
Publicado: (2021)

Monocyte-to-HDL Ratio (MHR) Predicts Vitamin D Deficiency in Healthy and Metabolic Women: A Cross-Sectional Study in 1048 Subjects
por: De Matteis, Carlo, et al.
Publicado: (2022)

Gender, BMI and fasting hyperglycaemia influence Monocyte to-HDL ratio (MHR) index in metabolic subjects
por: Battaglia, Stefano, et al.
Publicado: (2020)

let-7e downregulation characterizes early phase colonic adenoma in APC(Min/+) mice and human FAP subjects
por: Contursi, Annalisa, et al.
Publicado: (2021)

Pharmacological Activation of the Bile Acid Nuclear Farnesoid X Receptor Is Feasible in Patients with Quiescent Crohn's Colitis
por: van Schaik, Fiona D. M., et al.
Publicado: (2012)

Deciphering the nuclear bile acid receptor FXR paradigm
por: Modica, Salvatore, et al.
Publicado: (2010)

LXRs, SHP, and FXR in Prostate Cancer: Enemies or Ménage à Quatre With AR?
por: Cariello, Marica, et al.
Publicado: (2018)

Platelets from patients with visceral obesity promote colon cancer growth
por: Cariello, Marica, et al.
Publicado: (2022)

Identification of peculiar gene expression profile in peripheral blood mononuclear cells (PBMC) of celiac patients on gluten free diet
por: Sangineto, Moris, et al.
Publicado: (2018)

Farnesoid X Receptor (FXR) Activation and FXR Genetic Variation in Inflammatory Bowel Disease
por: Nijmeijer, Rian M., et al.
Publicado: (2011)

Protecting patients with IBD during the COVID-19 pandemic
por: Fiorino, Gionata, et al.
Publicado: (2020)

The Farnesoid X Receptor: Good for BAD
por: Keely, Stephen J., et al.
Publicado: (2016)

The Multiple Faces of Integrin–ECM Interactions in Inflammatory Bowel Disease
por: Garlatti, Valentina, et al.
Publicado: (2021)

Farnesoid X receptor (FXR): Structures and ligands
por: Jiang, Longying, et al.
Publicado: (2021)

The IL23-IL17 Immune Axis in the Treatment of Ulcerative Colitis: Successes, Defeats, and Ongoing Challenges
por: Noviello, Daniele, et al.
Publicado: (2021)

Analysis of fecal bile acids and metabolites by high resolution mass spectrometry in farm animals and correlation with microbiota
por: Porru, Emanuele, et al.
Publicado: (2022)

The central role of the gut in intensive care
por: Corriero, Alberto, et al.
Publicado: (2022)

Diabetic Nephropathy Is Accelerated by Farnesoid X Receptor Deficiency and Inhibited by Farnesoid X Receptor Activation in a Type 1 Diabetes Model
por: Wang, Xiaoxin X., et al.
Publicado: (2010)

Molecular tuning of farnesoid X receptor partial agonism
por: Merk, Daniel, et al.
Publicado: (2019)

Microbiota-induced obesity requires farnesoid X receptor
por: Parséus, Ava, et al.
Publicado: (2017)

Role of Farnesoid X Receptor in the Pathogenesis of Respiratory Diseases
por: Wu, Jin-nan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t09euphvgrf49575e5i5hopl66